Melani E, Sardanelli F, Ottonello C, Parodi R C, Castaldi A, Succi S
Istituto di Radiologia, Università degli Studi, Genova.
Radiol Med. 1995 Mar;89(3):219-24.
Twenty patients with clinically suspected breast cancer recurrence underwent MRI before and after paramagnetic contrast agent administration (MR mammography, MRM), after negative (4/20), questionable (11/20) or positive (5/20) X-ray mammography (XM). Spin-echo T1-weighted images before and after the i.v. administration of Gd-DTPA (0.15 mmol/kg) were acquired at 1, 3, 5, 7 and 10 minutes. Tissue behavior was studied directly on the images (qualitative analysis) and with dynamic curves of the signal-to-noise ratio and of enhancement rate (quantitative analysis). The histologic examination was performed in all cases--18 of them by surgical excision and in two by needle biopsy only. Seven of seven recurrences exhibited early (at 1 and 3 minutes) and focal qualitative enhancement, exceeding 100% at the quantitative analysis. Twelve of thirteen non-recurrences exhibited no significant qualitative enhancement, less than 40% at the quantitative analysis, while the extant lesion exhibited multifocal delayed (at 5-10 minutes) qualitative enhancement, about 60% at the quantitative analysis, and slight bilateral diffuse enhancement (proliferative dysplasia). MRM had 100% sensitivity, 92.3% specificity, 87.5% positive predictive value and 100% negative predictive value. XM had 100%, 30.8%, 43.7% and 100%, respectively (if we consider as positive all the questionable XM cases). To conclude, MRM is confirmed as a useful imaging technique in suspected breast cancer recurrences, especially after questionable XM exams.
20例临床怀疑乳腺癌复发的患者在静脉注射顺磁性造影剂前后接受了MRI检查(乳腺磁共振成像,MRM),这些患者的X线钼靶检查(XM)结果分别为阴性(4/20)、可疑(11/20)或阳性(5/20)。静脉注射钆喷酸葡胺(Gd-DTPA,0.15 mmol/kg)后,于1、3、5、7和10分钟采集自旋回波T1加权图像。直接在图像上研究组织行为(定性分析),并利用信噪比和增强率的动态曲线进行研究(定量分析)。所有病例均进行了组织学检查,其中18例通过手术切除,2例仅通过针吸活检。7例复发中有7例表现为早期(1和3分钟时)局灶性定性增强,定量分析时超过100%。13例非复发中有12例无明显定性增强,定量分析时低于40%,而现存病变表现为多灶性延迟(5 - 10分钟时)定性增强,定量分析时约为60%,并伴有轻微双侧弥漫性增强(增殖性发育异常)。MRM的敏感性为100%,特异性为92.3%,阳性预测值为87.5%,阴性预测值为100%。XM的敏感性、特异性、阳性预测值和阴性预测值分别为100%、30.8%、43.7%和100%(如果将所有可疑的XM病例视为阳性)。总之,MRM被证实是一种用于可疑乳腺癌复发的有用成像技术,尤其是在XM检查结果可疑之后。